Clinical trial
A Randomized, Open-Label, 2-period, 2-sequence, Crossover Food-Effect Study of KH607 Tablets in Healthy Chinese Participants
NCT07634874 is registered in ClinicalTrials.gov with Chengdu Kanghong Pharmaceutical Group Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-Label, 2-period, 2-sequence, Crossover Food-Effect Study of KH607 Tablets in Healthy Chinese Participants
- Lead sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- July 31, 2026
- Enrollment
- 16 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
food effect of kh607 in chinese health participants